Clinical Relevant Polymorphisms Affecting Clopidogrel Pharmacokinetics and Pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program.

Hernandez-Suarez DF, Tomassini-Fernandini JC, Cuevas A, Rosario-Berrios AN, Nu?ez-Medina HJ, Padilla-Arroyo D, Rivera N, Liriano J, Vega-Roman RK, Renta JY, Melin K, Duconge J. Clinical Relevant Polymorphisms Affecting Clopidogrel Pharmacokinetics and Pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program. Int J Environ Res Public Health. 2018 05 30; 15(6).

View in: PubMed

subject areas

Aryldialkylphosphatase
Cross-Sectional Studies
Female
Gene Frequency
Genetic Markers
Genotype
Humans
Infant, Newborn
Male
Neonatal Screening
Pharmacogenetics
Platelet Aggregation Inhibitors
Polymorphism, Single Nucleotide
Puerto Rico

authors with profiles

Kyle Melin
Jorge Duconge

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support